Unexpected Pediatric Cardiac Arrest in a Toddler: A Case of Catecholaminergic Polymorphic Ventricular Tachycardia Presenting as Ventricular Fibrillation.

Pediatr Emerg CareApr 13, 2026 (epub)

Abiezer Disla Cuevas, Chantel Tran, Mohamud Daya et al.

✦ AI-curated · Sources linked

Case in brief

A previously healthy 2-year-old boy became pulseless after collapsing during a tantrum. EMS found ventricular fibrillation and delivered a 70-J biphasic shock (~4 J/kg), restoring circulation. He later had episodes of seizure-like posturing and limb rigidity, while his baseline ECG showed sinus tachycardia and echocardiography found no structural abnormality. An epinephrine challenge provoked bidirectional ventricular tachycardia, supporting catecholaminergic polymorphic ventricular tachycardia (CPVT); genetic testing identified a likely pathogenic RYR2 variant. He was discharged on propranolol and flecainide, with a loaner AED and outpatient follow-up arranged.

What made this case unusual

The toddler’s CPVT presented as ventricular fibrillation arrest, with subsequent seizure-like episodes that could represent recurrent arrhythmia; the resting ECG and echocardiogram were unremarkable.

Diagnostic / clinical pearl

In a child resuscitated from ventricular fibrillation, seizure-like posturing may reflect recurrent arrhythmia. A normal baseline ECG and structurally normal heart do not exclude CPVT; in this case, epinephrine challenge provoked diagnostic bidirectional ventricular tachycardia.

Why it matters

The case underscores the importance of prompt prehospital rhythm recognition and defibrillation in pediatric cardiac arrest.

Source

Published in Pediatr Emerg Care. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.